The landscape of obesity treatment is undergoing a revolutionary shift with the emergence of innovative medications. Tirzepatide , initially developed for diabetes, has demonstrated remarkable efficacy in promoting slimming, and now Cagrilintide joins the ranks, also showing promising benefits in